Search
Now showing items 1-1 of 1
Comparison of stage III mucinous and serous ovarian cancer: a case-control study
(2018)
Background: The purpose of this case-control study was to compare the prognoses of women with stage III mucinous ovarian carcinoma (MOC) who received maximal or optimal cytoreduction followed by paclitaxel plus carboplatin ...